Covid-19: Moderna CEO says data for Omicron-specific shot likely available in March
Bancel said the best case scenario was the combined COVID/flu vaccine would be available by the fall of 2023, at least in some countries. Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around … Read more